Friday, March 27, 2026 11:23:33 AM
LET ME PAINT YOU PICTURE... GW Pharmaceutical years ago developed a Epilepsy drug made from cannabis , the drug got FDA Approval... An is still the only FDA cannabis drug Approved made from cannabis.. GW was bought by Jazz Pharmaceuticals.. The stock traded once at $9.00 and ran to over $320.00 plus.. Charlotte's Web has a drug in the 2nd phase of FDA clinical trials... Also the Stanley Brothers have proof of effective results treating seizures with CBD with tremendous success with the companies name sake Charlotte Figi it saved her life.. These drug get FDA approval Charlotte's Web stock will be way passed a dollar.... Charlotte's Web has British American tobacco in the game with a 19.8% to 19.9% ownership stake in Charlotte'sWeb... Here's another example one big investment and this will go up huge... Canopy Growth Corp 2017-2018): Constellation Brands first took a 9.9% stake for C$245 million in 2017, followed by a major $4 billion investment in 2018, which brought their ownership stake to approximately 38%.. My point Canopy went from $3 to $5 bucks to over $60.00... News coming : rescheduling finalized , Medicare and Medicaid revenue added to the following Quarters added to the bottom line at the end of the year.... Great Possible buy out opportunity here.. Jazz just posted 1 billion in revenue from the Only FDA approved Cannabis Epilepsy drug... The potential here's is huge especially with FDA drug approval... Lots of eyes on this not to mentioned out of all the Cannabis companies im aware of.. Charlotte's Web is the only one with company staff with pictures in the Ovel office when Donald Trump signed the executive order rescheduling cannabis... Also i seen huge blocks being bought at 0.68 this morning 52,000 , 68,000 , 35,000.. Big money wants in...
Bullish
Recent CWBHF News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/16/2026 07:03:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 07:03:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 07:02:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 04:30:15 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/06/2026 09:07:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:29:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 11:18:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 09:30:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/01/2026 09:29:45 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 11:08:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:07:30 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 11:07:11 AM
- Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results • PR Newswire (US) • 03/31/2026 11:07:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 10:46:21 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 10:45:01 AM
- Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet • PR Newswire (US) • 03/31/2026 02:59:00 AM
- Charlotte's Web 2025 Fourth Quarter and Year-End Earnings Call and Webcast Notice • PR Newswire (US) • 03/24/2026 01:15:00 PM
- Charlotte's Web Welcomes New CMS Guidance, Advancing Access to Eligible Full‑Spectrum Hemp Products • PR Newswire (US) • 03/21/2026 01:53:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 03:19:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 12:14:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:07:22 PM
